Investing


Intuitive Surgical’s robots will expand to new applications and boost the company’s sales, according to a top Wall Street firm.

Goldman Sachs reiterated its buy rating for the surgical robot maker, predicting the company will report earnings above expectations next year.

“Our latest checks with management and physician users leave us incrementally bullish on the new product pipeline and opportunities for robotic surgery to expand into new applications,” analyst Isaac Ro wrote in a note to clients Thursday.

We “see the potential for further upside if lung biopsy and hernia markets become significant. Our higher price target is a function of higher target multiples, which we justify given our increased confidence in the growth outlook vs. Med Tech peers.”



Source link

Products You May Like

Articles You May Like

KFC branches in Britain to remain closed amid ongoing chicken shortage
Worldpay and Visa reversing duplicate transactions for Coinbase users
Airbus A380 program could be ‘sustainable’ after Emirates purchase, top exec says
Ethereum creator Vitalik Buterin warns about cryptocurrency investment
State pensions and fund companies feel heat over their gun stock investments

Leave a Reply

Your email address will not be published. Required fields are marked *